MTVA
MetaViaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MTVA vs peer average
59/100
MTVA vs. peer average (D vs. F)
Grade spread
B 1 · D 2 · F 8
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
APVO is the first available peer comparator.
Another very small-cap biotech where capital access and headline cadence matter more than current fundamentals, making it a useful risk-frame comp despite limited operating overlap.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MTVA
MetaVia
APVO
Aptevo Therapeutics
Grade
D
F
Momentum
69
18
Value
59
58
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs APVO
MTVA / APVO
Grade Position
In line
MTVA vs. peer average (D vs. F)
59/100
Momentum
69
MTVAValue
59
MTVASentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MTVA
APVO is the first peer returned for this comparison set.